Home
Conditions
Lymphatic Diseases

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,982 public trials 1,832 recruiting studies

Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Recruiting

AI-assisted Diagnosis of Malignant Brain Tumors

NCT07198256

Conditions: Brain Diseases, Brain Metastases, Adult, Brain Neoplasms, +21 more
Locations: 2nd Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China

Zhejiang Cancer Hospital Hangzhou, Zhejiang, China

View Trial Details

Recruiting

Open-label of Loncastuximab Tesirine (ADCT-402) in Relapsed/Refractory Marginal Zone Lymphoma

NCT05296070

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: City of Hope National Medical Center Duarte, California, United States

University of Miami Miami, Florida, United States

Emory University Atlanta, Georgia, United States

Vanderbilt University Nashville, Tennessee, United States

View Trial Details

Recruiting

Orelabrutinib and Rituximab With Optional Autologous Hematopoietic Stem Cell Transplantation in MCL Treatment

NCT07199296

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Ruijin Hospital Shanghai, China

View Trial Details

Recruiting

European and North Indian Cohort of KaWasaki dIsease

NCT06305611

Conditions: Cardiovascular Diseases, Hemic and Lymphatic Diseases, Kawasaki Disease, +7 more
Locations: Universidade Federal do Rio de Janeiro Rio de Janeiro, Brazil

Children's Hospital Zagreb Zagreb, Croatia

University Hospital Centre Zagreb, University School of Medicine Zagreb, Croatia

Le Kremlin-Bicetre University Hospital, Paris-Sud University - CEREMAI Le Kremlin-Bicêtre, France

View all 27 locations

View Trial Details

Recruiting

A Study of GNC-038 Injection in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

NCT05623982

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

Harbin First Hospital Haerbin, Heilongjing, China

Qingdao Central Hospital Qingdao, Shandong, China

View Trial Details

Recruiting

Telerehabilitation in Hemato-oncological Survivors

NCT05779605

Conditions: Hematologic Diseases, Hematologic Malignancy, Hematologic Neoplasms, +9 more
Locations: University Hospital Brno Brno, Czechia

View Trial Details

Recruiting

MEN1703 (SEL24) to Treat Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma (JASPIS-01)

NCT06534437

Conditions: Aberrant Motor Behavior in Dementia, Aggression, Behavior, +16 more
Locations: Centre Hospitalier Le Mans Le Mans, France

CHU de Lille - Hôpital Claude Huriez Lille, France

CHU de Limoges - CHU Dupuytren Limoges, France

Hospices Civils De Lyon - Hôpital Lyon Sud Lyon, France

View all 36 locations

View Trial Details

Recruiting

Linperlisib Combination With Cyclophosphamide, Prednisone, and Thalidomide (CPT) in R/R NHL

NCT07195799

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China

View Trial Details

Recruiting

Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies

NCT06398457

Conditions: Acute Lymphoblastic Leukemia (ALL), Adult, Acute Myeloid Leukemia (AML), Anemia, +45 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Recruiting

Clinical Trial Using CAR- T Cells for Treatment of Patients With Refractory or Relapsed CD19-positive B Lymphoid Malignancies

NCT05705570

Conditions: Acute Lymphoblastic Leukemia Refractory, Acute Lymphoblastic Leukemia, in Relapse, B-cell Lymphoma Recurrent, +14 more
Locations: Hospital Israelita Albert Einstein São Paulo, Brazil

View Trial Details

Lymphatic Diseases

Lymphatic Diseases trial results

Related conditions